The DOI matches its Crossref record; 100 of the 100 references it cites were found in a registry or an index.
Impact of GPCR Structures on Drug Discovery
Open accessAbstract
Structures of 70 unique G protein-coupled receptors (GPCRs) have been determined, with over 370 structures in total bound to different ligands and the receptors in various conformational states. Structure-based drug design has been applied to an increasing number of GPCR targets over the past decade and now a few of these drug candidates have entered clinical trials. Given the length of time required for a drug to reach the market, there are no documented examples of licensed drugs being developed with the aid of a structure, but this is likely to change as current efforts come to fruition.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
New tools for automated high-resolution cryo-EM structure determination in RELION-3
Zivanov, J., Nakane, T., Forsberg, B. O., Kimanius, D., Hagen, W. J., Lindahl, E., & Scheres, S. H. (2018) · eLife · doi:10.7554/elife.42166 · Cited by 4,621
High-Resolution Crystal Structure of an Engineered Human β 2 -Adrenergic G Protein–Coupled Receptor
Cherezov, V., Rosenbaum, D. M., Hanson, M. A., Rasmussen, S. G. F., Thian, F. S., Kobilka, T. S., Choi, H.-J., Kuhn, P., Weis, W. I., Kobilka, B. K., et al. (2007) · Science · doi:10.1126/science.1150577 · Cited by 3,264
Crystal structure of the β2 adrenergic receptor–Gs protein complex
Rasmussen, S. G. F., DeVree, B. T., Zou, Y., Kruse, A. C., Chung, K. Y., Kobilka, T. S., Thian, F. S., Chae, P. S., Pardon, E., Calinski, D., et al. (2011) · Nature · doi:10.1038/nature10361 · Cited by 3,009
Trends in GPCR drug discovery: new agents, targets and indications
Hauser, A. S., Attwood, M. M., Rask-Andersen, M., Schiöth, H. B., & Gloriam, D. E. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.178 · Cited by 2,627
The structure and function of G-protein-coupled receptors
Rosenbaum, D. M., Rasmussen, S. G. F., & Kobilka, B. K. (2009) · Nature · doi:10.1038/nature08144 · Cited by 2,534
A comprehensive map of molecular drug targets
Santos, R., Ursu, O., Gaulton, A., Bento, A. P., Donadi, R. S., Bologa, C. G., Karlsson, A., Al-Lazikani, B., Hersey, A., Oprea, T. I., et al. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.230 · Cited by 2,427
Gaulton, A., Hersey, A., Nowotka, M., Bento, A. P., Chambers, J., Mendez, D., Mutowo, P., Atkinson, F., Bellis, L. J., Cibrián-Uhalte, E., et al. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkw1074 · Cited by 2,330
Metabotropic Glutamate Receptors: Physiology, Pharmacology, and Disease
Niswender, C. M., & Conn, P. J. (2010) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.011008.145533 · Cited by 1,892
Alteration of Lymphocyte Trafficking by Sphingosine-1-Phosphate Receptor Agonists
Mandala, S., Hajdu, R., Bergstrom, J., Quackenbush, E., Xie, J., Milligan, J., Thornton, R., Shei, G.-J., Card, D., Keohane, C., et al. (2002) · Science · doi:10.1126/science.1070238 · Cited by 1,690
Structure of a nanobody-stabilized active state of the β2 adrenoceptor
Rasmussen, S. G. F., Choi, H.-J., Fung, J. J., Pardon, E., Casarosa, P., Chae, P. S., DeVree, B. T., Rosenbaum, D. M., Thian, F. S., Kobilka, T. S., et al. (2011) · Nature · doi:10.1038/nature09648 · Cited by 1,680
Molecular signatures of G-protein-coupled receptors
Venkatakrishnan, A. J., Deupi, X., Lebon, G., Tate, C. G., Schertler, G. F., & Babu, M. M. (2013) · Nature · doi:10.1038/nature11896 · Cited by 1,497
Self-citationGPCR Engineering Yields High-Resolution Structural Insights into β 2 -Adrenergic Receptor Function
Rosenbaum, D. M., Cherezov, V., Hanson, M. A., Rasmussen, S. G. F., Thian, F. S., Kobilka, T. S., Choi, H.-J., Yao, X.-J., Weis, W. I., Stevens, R. C., et al. (2007) · Science · doi:10.1126/science.1150609 · Cited by 1,336
The Molecular Basis of G Protein–Coupled Receptor Activation
Weis, W. I., & Kobilka, B. K. (2018) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-060614-033910 · Cited by 1,227
Crystal structure of opsin in its G-protein-interacting conformation
Scheerer, P., Park, J. H., Hildebrand, P. W., Kim, Y. J., Krauß, N., Choe, H.-W., Hofmann, K. P., & Ernst, O. P. (2008) · Nature · doi:10.1038/nature07330 · Cited by 1,059
Ultra-large library docking for discovering new chemotypes
Lyu, J., Wang, S., Balius, T. E., Singh, I., Levit, A., Moroz, Y. S., O’Meara, M. J., Che, T., Algaa, E., Tolmachova, K., et al. (2019) · Nature · doi:10.1038/s41586-019-0917-9 · Cited by 998
Structure and dynamics of GPCR signaling complexes
Hilger, D., Masureel, M., & Kobilka, B. K. (2018) · Nature Structural & Molecular Biology · doi:10.1038/s41594-017-0011-7 · Cited by 969
Structure-based discovery of opioid analgesics with reduced side effects
Manglik, A., Lin, H., Aryal, D. K., McCorvy, J. D., Dengler, D., Corder, G., Levit, A., Kling, R. C., Bernat, V., Hübner, H., et al. (2016) · Nature · doi:10.1038/nature19112 · Cited by 944
Crystal structure of the ligand-free G-protein-coupled receptor opsin
Park, J. H., Scheerer, P., Hofmann, K. P., Choe, H.-W., & Ernst, O. P. (2008) · Nature · doi:10.1038/nature07063 · Cited by 903
Biased signalling: from simple switches to allosteric microprocessors
Smith, J. S., Lefkowitz, R. J., & Rajagopal, S. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.229 · Cited by 738
Mechanisms of signalling and biased agonism in G protein-coupled receptors
Wootten, D., Christopoulos, A., Marti-Solano, M., Babu, M. M., & Sexton, P. M. (2018) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-018-0049-3 · Cited by 724
Allosteric Modulation of G Protein–Coupled Receptors
May, L. T., Leach, K., Sexton, P. M., & Christopoulos, A. (2007) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.47.120505.105159 · Cited by 695
Conformational complexity of G-protein-coupled receptors
Kobilka, B. K., & Deupi, X. (2007) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2007.06.003 · Cited by 694
Bodick, N. C., Offen, W. W., Levey, A. I., Cutler, N. R., Gauthier, S. G., Satlin, A., Shannon, H. E., Tollefson, G. D., Rasmussen, K., Bymaster, F. P., et al. (1997) · Archives of Neurology · doi:10.1001/archneur.1997.00550160091022 · Cited by 692
Whorton, M. R., Bokoch, M. P., Rasmussen, S. G. F., Huang, B., Zare, R. N., Kobilka, B., & Sunahara, R. K. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0611448104 · Cited by 675
Crystal Structure of a Lipid G Protein–Coupled Receptor
Hanson, M. A., Roth, C. B., Jo, E., Griffith, M. T., Scott, F. L., Reinhart, G., Desale, H., Clemons, B., Cahalan, S. M., Schuerer, S. C., et al. (2012) · Science · doi:10.1126/science.1215904 · Cited by 666
Baldwin, J. M., Schertler, G. F. X., & Unger, V. M. (1997) · Journal of Molecular Biology · doi:10.1006/jmbi.1997.1240 · Cited by 643
The structural basis for agonist and partial agonist action on a β1-adrenergic receptor
Warne, T., Moukhametzianov, R., Baker, J. G., Nehmé, R., Edwards, P. C., Leslie, A. G. W., Schertler, G. F. X., & Tate, C. G. (2011) · Nature · doi:10.1038/nature09746 · Cited by 618
Self-citationInternational Union of Pharmacology. XLVI. G Protein-Coupled Receptor List
Foord, S. M., Bonner, T. I., Neubig, R. R., Rosser, E. M., Pin, J.-P., Davenport, A. P., Spedding, M., & Harmar, A. J. (2005) · Pharmacological Reviews · doi:10.1124/pr.57.2.5 · Cited by 592
How Ligands Illuminate GPCR Molecular Pharmacology
Wacker, D., Stevens, R. C., & Roth, B. L. (2017) · Cell · doi:10.1016/j.cell.2017.07.009 · Cited by 560
GABAA receptor signalling mechanisms revealed by structural pharmacology
Masiulis, S., Desai, R., Uchański, T., Serna Martin, I., Laverty, D., Karia, D., Malinauskas, T., Zivanov, J., Pardon, E., Kotecha, A., et al. (2019) · Nature · doi:10.1038/s41586-018-0832-5 · Cited by 551
Glucagon-like peptide 1 in health and disease
Andersen, A., Lund, A., Knop, F. K., & Vilsbøll, T. (2018) · Nature Reviews Endocrinology · doi:10.1038/s41574-018-0016-2 · Cited by 543
Therapeutic potential of β-arrestin- and G protein-biased agonists
Whalen, E. J., Rajagopal, S., & Lefkowitz, R. J. (2011) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2010.11.004 · Cited by 510
Emerging paradigms in GPCR allostery: implications for drug discovery
Wootten, D., Christopoulos, A., & Sexton, P. M. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4052 · Cited by 498
Fusion Partner Toolchest for the Stabilization and Crystallization of G Protein-Coupled Receptors
Chun, E., Thompson, A. A., Liu, W., Roth, C. B., Griffith, M. T., Katritch, V., Kunken, J., Xu, F., Cherezov, V., Hanson, M. A., et al. (2012) · Structure · doi:10.1016/j.str.2012.04.010 · Cited by 461
Arrangement of rhodopsin transmembrane α-helices
Unger, V. M., Hargrave, P. A., Baldwin, J. M., & Schertler, G. F. X. (1997) · Nature · doi:10.1038/38316 · Cited by 454
Structure of the adenosine A2A receptor bound to an engineered G protein
Carpenter, B., Nehmé, R., Warne, T., Leslie, A. G. W., & Tate, C. G. (2016) · Nature · doi:10.1038/nature18966 · Cited by 435
Self-citationTargeting adenosine A2A receptors in Parkinson's disease
Schwarzschild, M. A., Agnati, L., Fuxe, K., Chen, J.-F., & Morelli, M. (2006) · Trends in Neurosciences · doi:10.1016/j.tins.2006.09.004 · Cited by 433
Universal allosteric mechanism for Gα activation by GPCRs
Flock, T., Ravarani, C. N. J., Sun, D., Venkatakrishnan, A. J., Kayikci, M., Tate, C. G., Veprintsev, D. B., & Babu, M. M. (2015) · Nature · doi:10.1038/nature14663 · Cited by 365
Self-citationCrystal structures of the M1 and M4 muscarinic acetylcholine receptors
Thal, D. M., Sun, B., Feng, D., Nawaratne, V., Leach, K., Felder, C. C., Bures, M. G., Evans, D. A., Weis, W. I., Bachhawat, P., et al. (2016) · Nature · doi:10.1038/nature17188 · Cited by 335
Mini-G proteins: Novel tools for studying GPCRs in their active conformation
Nehmé, R., Carpenter, B., Singhal, A., Strege, A., Edwards, P. C., White, C. F., Du, H., Grisshammer, R., & Tate, C. G. (2017) · PLOS ONE · doi:10.1371/journal.pone.0175642 · Cited by 323
Self-citationStructural insights into G-protein-coupled receptor allostery
Thal, D. M., Glukhova, A., Sexton, P. M., & Christopoulos, A. (2018) · Nature · doi:10.1038/s41586-018-0259-z · Cited by 319
The GPCR Network: a large-scale collaboration to determine human GPCR structure and function
Stevens, R. C., Cherezov, V., Katritch, V., Abagyan, R., Kuhn, P., Rosen, H., & Wüthrich, K. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd3859 · Cited by 316
Diverse activation pathways in class A GPCRs converge near the G-protein-coupling region
Venkatakrishnan, A. J., Deupi, X., Lebon, G., Heydenreich, F. M., Flock, T., Miljus, T., Balaji, S., Bouvier, M., Veprintsev, D. B., Tate, C. G., et al. (2016) · Nature · doi:10.1038/nature19107 · Cited by 308
Self-citationCongreve, M., Andrews, S. P., Doré, A. S., Hollenstein, K., Hurrell, E., Langmead, C. J., Mason, J. S., Ng, I. W., Tehan, B., Zhukov, A., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm201376w · Cited by 305
Self-citationImmuno-Oncology: Emerging Targets and Combination Therapies
Marshall, H. T., & Djamgoz, M. B. A. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00315 · Cited by 301
Structure-based drug screening for G-protein-coupled receptors
Shoichet, B. K., & Kobilka, B. K. (2012) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2012.03.007 · Cited by 294
Immunosuppressive Activities of Adenosine in Cancer
Allard, B., Beavis, P. A., Darcy, P. K., & Stagg, J. (2016) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2016.04.001 · Cited by 292
Allosteric coupling from G protein to the agonist-binding pocket in GPCRs
DeVree, B. T., Mahoney, J. P., Vélez-Ruiz, G. A., Rasmussen, S. G. F., Kuszak, A. J., Edwald, E., Fung, J.-J., Manglik, A., Masureel, M., Du, Y., et al. (2016) · Nature · doi:10.1038/nature18324 · Cited by 290
Comi, G., Kappos, L., Selmaj, K. W., Bar-Or, A., Arnold, D. L., Steinman, L., Hartung, H.-P., Montalban, X., Kubala Havrdová, E., Cree, B. A. C., et al. (2019) · The Lancet Neurology · doi:10.1016/s1474-4422(19)30239-x · Cited by 285
Status of GPCR Modeling and Docking as Reflected by Community-wide GPCR Dock 2010 Assessment
Kufareva, I., Rueda, M., Katritch, V., Stevens, R. C., & Abagyan, R. (2011) · Structure · doi:10.1016/j.str.2011.05.012 · Cited by 281
Community-wide assessment of GPCR structure modelling and ligand docking: GPCR Dock 2008
participants, G. D. 2., Michino, M., Abola, E., Brooks, C. L., Dixon, J. S., Moult, J., & Stevens, R. C. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2877 · Cited by 276
D4dopamine receptor high-resolution structures enable the discovery of selective agonists
Wang, S., Wacker, D., Levit, A., Che, T., Betz, R. M., McCorvy, J. D., Venkatakrishnan, A. J., Huang, X.-P., Dror, R. O., Shoichet, B. K., et al. (2017) · Science · doi:10.1126/science.aan5468 · Cited by 261
Cryo-EM structure of human rhodopsin bound to an inhibitory G protein
Kang, Y., Kuybeda, O., de Waal, P. W., Mukherjee, S., Van Eps, N., Dutka, P., Zhou, X. E., Bartesaghi, A., Erramilli, S., Morizumi, T., et al. (2018) · Nature · doi:10.1038/s41586-018-0215-y · Cited by 261
Structure-Based Discovery of Novel Chemotypes for Adenosine A2AReceptor Antagonists
Katritch, V., Jaakola, V.-P., Lane, J. R., Lin, J., IJzerman, A. P., Yeager, M., Kufareva, I., Stevens, R. C., & Abagyan, R. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm901647p · Cited by 245
Structure-Based Discovery of A 2A Adenosine Receptor Ligands
Carlsson, J., Yoo, L., Gao, Z.-G., Irwin, J. J., Shoichet, B. K., & Jacobson, K. A. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100240h · Cited by 227
McMullan, G., Faruqi, A. R., & Henderson, R. A. (2016) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/bs.mie.2016.05.056 · Cited by 214
Single particle electron cryomicroscopy: trends, issues and future perspective
Vinothkumar, K. R., & Henderson, R. (2016) · Quarterly Reviews of Biophysics · doi:10.1017/s0033583516000068 · Cited by 206
de Graaf, C., Kooistra, A. J., Vischer, H. F., Katritch, V., Kuijer, M., Shiroishi, M., Iwata, S., Shimamura, T., Stevens, R. C., de Esch, I. J. P., et al. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm2011589 · Cited by 204
Self-citationBristow, M. R. (2011) · Circulation Research · doi:10.1161/circresaha.111.245092 · Cited by 173
Engineering G protein-coupled receptors to facilitate their structure determination
Tate, C. G., & Schertler, G. F. (2009) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2009.07.004 · Cited by 171
Self-citationAdvances in GPCR Modeling Evaluated by the GPCR Dock 2013 Assessment: Meeting New Challenges
Kufareva, I., Katritch, V., Stevens, R. C., & Abagyan, R. (2014) · Structure · doi:10.1016/j.str.2014.06.012 · Cited by 169
Allosteric functioning of dimeric class C G‐protein‐coupled receptors
Pin, J., Kniazeff, J., Liu, J., Binet, V., Goudet, C., Rondard, P., & Prézeau, L. (2005) · The FEBS Journal · doi:10.1111/j.1742-4658.2005.04728.x · Cited by 167
Christopher, J. A., Aves, S. J., Bennett, K. A., Doré, A. S., Errey, J. C., Jazayeri, A., Marshall, F. H., Okrasa, K., Serrano-Vega, M. J., Tehan, B. G., et al. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00892 · Cited by 165
Self-citationStructural Insights into the Process of GPCR-G Protein Complex Formation
Liu, X., Xu, X., Hilger, D., Aschauer, P., Tiemann, J. K. S., Du, Y., Liu, H., Hirata, K., Sun, X., Guixà-González, R., et al. (2019) · Cell · doi:10.1016/j.cell.2019.04.021 · Cited by 165
Carpenter, B., & Tate, C. G. (2016) · Protein Engineering Design and Selection · doi:10.1093/protein/gzw049 · Cited by 161
Self-citationCryo-EM structures of GPCRs coupled to Gs, Gi and Go
García‐Nafría, J., & Tate, C. G. (2019) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2019.02.006 · Cited by 160
Self-citationβ2‐adrenoceptor agonists: current and future direction
Cazzola, M., Calzetta, L., & Matera, M. G. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01216.x · Cited by 158
Milligan, G., Ward, R. J., & Marsango, S. (2018) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2018.10.007 · Cited by 148
Identification of Novel Adenosine A2A Receptor Antagonists by Virtual Screening
Langmead, C. J., Andrews, S. P., Congreve, M., Errey, J. C., Hurrell, E., Marshall, F. H., Mason, J. S., Richardson, C. M., Robertson, N. J., Zhukov, A., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm201455y · Cited by 145
Self-citationMoran, S. P., Maksymetz, J., & Conn, P. J. (2019) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2019.10.007 · Cited by 142
Targeting of Smoothened for therapeutic gain
Ruat, M., Hoch, L., Faure, H., & Rognan, D. (2014) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2014.03.002 · Cited by 131
García‐Nafría, J., & Tate, C. G. (2019) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010919-023545 · Cited by 130
Self-citationBiophysical Mapping of the Adenosine A2A Receptor
Zhukov, A., Andrews, S. P., Errey, J. C., Robertson, N. J., Tehan, B. G., Mason, J. S., Marshall, F. H., Weir, M., & Congreve, M. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm2003798 · Cited by 129
Self-citationLoss of Muscarinic M1 Receptor Exacerbates Alzheimer's Disease–Like Pathology and Cognitive Decline
Medeiros, R., Kitazawa, M., Caccamo, A., Baglietto‐Vargas, D., Estrada-Hernandez, T., Cribbs, D. H., Fisher, A., & LaFerla, F. M. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.04.041 · Cited by 127
Structural Analysis of Chemokine Receptor–Ligand Interactions
Arimont, M., Sun, S., Leurs, R., Smit, M. J., de Esch, I. J. P., & de Graaf, C. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b01309 · Cited by 126
Molecular basis for high-affinity agonist binding in GPCRs
Warne, T., Edwards, P. C., Dore, A. S., Leslie, A. G. W., & Tate, C. G. (2019) · Science · doi:10.1126/science.aau5595 · Cited by 117
Self-citationMagnani, F., Serrano‐Vega, M. J., Shibata, Y., Abdul-Hussein, S., Lebon, G., Miller-Gallacher, J., Singhal, A., Strege, A., Thomas, J. A., & Tate, C. G. (2016) · Nature Protocols · doi:10.1038/nprot.2016.088 · Cited by 103
Self-citationStructures of the Rhodopsin-Transducin Complex: Insights into G-Protein Activation
Gao, Y., Hu, H., Ramachandran, S., Erickson, J. W., Cerione, R. A., & Skiniotis, G. (2019) · Molecular Cell · doi:10.1016/j.molcel.2019.06.007 · Cited by 101
Agonist-bound structures of G protein-coupled receptors
Lebon, G., Warne, T., & Tate, C. G. (2012) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2012.03.007 · Cited by 99
Self-citationChristopher, J. A., Orgován, Z., Congreve, M., Dore, A. S., Errey, J. C., Marshall, F. H., Mason, J. S., Okrasa, K., Rucktooa, P., Serrano‐Vega, M. J., et al. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b01722 · Cited by 96
Self-citationTowards high throughput GPCR crystallography: In Meso soaking of Adenosine A2A Receptor crystals
Rucktooa, P., Cheng, R. K. Y., Segala, E., Geng, T., Errey, J. C., Brown, G. A., Cooke, R. M., Marshall, F. H., & Dore, A. S. (2018) · Scientific Reports · doi:10.1038/s41598-017-18570-w · Cited by 94
Function-specific virtual screening for GPCR ligands using a combined scoring method
Kooistra, A. J., Vischer, H. F., McNaught-Flores, D. A., Leurs, R., de Esch, I. J. P., & de Graaf, C. (2016) · Scientific Reports · doi:10.1038/srep28288 · Cited by 92
Rappas, M., Ali, A. A. E., Bennett, K. A., Brown, J. D., Bucknell, S. J., Congreve, M., Cooke, R. M., Cseke, G., de Graaf, C., Dore, A. S., et al. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b01787 · Cited by 88
Self-citationChemical Diversity in the G Protein-Coupled Receptor Superfamily
Vass, M., Kooistra, A. J., Yang, D., Stevens, R. C., Wang, M.-W., & de Graaf, C. (2018) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2018.02.004 · Cited by 87
Tsai, C., Pamula, F., Nehmé, R., Mühle, J., Weinert, T., Flock, T., Nogły, P., Edwards, P. C., Carpenter, B., Gruhl, T., et al. (2018) · Science Advances · doi:10.1126/sciadv.aat7052 · Cited by 86
Self-citationAminergic GPCR–Ligand Interactions: A Chemical and Structural Map of Receptor Mutation Data
Vass, M., Podlewska, S., de Esch, I. J. P., Bojarski, A. J., Leurs, R., Kooistra, A. J., & de Graaf, C. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b00836 · Cited by 72
The importance of ligands for G protein-coupled receptor stability
Zhang, X., Stevens, R. C., & Xu, F. (2015) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2014.12.005 · Cited by 71
Structure-Based Discovery of Selective Serotonin 5-HT 1B Receptor Ligands
Rodriguez, D. J., Brea, J. M., Loza, M. I., & Carlsson, J. (2014) · Structure · doi:10.1016/j.str.2014.05.017 · Cited by 60
Zheng, Z., Huang, X., Mangano, T. J., Zou, R., Chen, X., Zaidi, S. A., Roth, B. L., Stevens, R. C., & Katritch, V. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00109 · Cited by 59
Targeting adenosine A2A receptor antagonism for treatment of cancer
Congreve, M., Brown, G. A., Borodovsky, A., & Lamb, M. L. (2018) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2018.1534825 · Cited by 56
Self-citationStructural and Druggability Landscape of Frizzled G Protein-Coupled Receptors
Zhang, X., Dong, S., & Xu, F. (2018) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2018.09.002 · Cited by 50
The expanding toolkit for structural biology: synchrotrons, X-ray lasers and cryoEM
Muench, S. P., Antonyuk, S. V., & Hasnain, S. S. (2019) · IUCrJ · doi:10.1107/s2052252519002422 · Cited by 42
From Three-Dimensional GPCR Structure to Rational Ligand Discovery
Kooistra, A. J., Leurs, R., de Esch, I. J. P., & de Graaf, C. (2013) · Advances in experimental medicine and biology · doi:10.1007/978-94-007-7423-0_7 · Cited by 31
Crystal structure of the Orexin-1 receptor in complex with Compound 16
Rappas, M., Ali, A. A. E., Bennett, K. A., Brown, J. D., Bucknell, S. J., Congreve, M., Cooke, R. M., Cseke, G., de Graaf, C., Dore, A. S., et al. (2019) · Worldwide Protein Data Bank · doi:10.2210/pdb6tq4/pdb · Cited by 28
Self-citationInterrogating dense ligand chemical space with a forward-synthetic library
Chevillard, F., Stotani, S., Karawajczyk, A., Hristeva, S., Pardon, E., Steyaert, J., Tzalis, D., & Kolb, P. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1818718116 · Cited by 25
Tosh, D. K., Ciancetta, A., Warnick, E., Crane, S., Gao, Z., & Jacobson, K. A. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b01183 · Cited by 23
Docking Finds GPCR Ligands in Dark Chemical Matter
Ballante, F., Rudling, A., Zeifman, A. A., Luttens, A., Vo, D. D., Irwin, J. J., Kihlberg, J. O., Brea, J. M., Loza, M. I., & Carlsson, J. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b01560 · Cited by 23
Breakthrough in GPCR Crystallography and Its Impact on Computer-Aided Drug Design
Ciancetta, A., & Jacobson, K. A. (2017) · Methods in molecular biology · doi:10.1007/978-1-4939-7465-8_3 · Cited by 21
Lindemann, M., Hinz, S., Deuther‐Conrad, W., Namasivayam, V., Dukić-Stefanović, S., Teodoro, R., Toussaint, M., Kranz, M., Juhl, C., Steinbach, J., et al. (2018) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2018.07.045 · Cited by 20
Selvam, C., Thilagavathi, R., Narasimhan, B., Kumar, P., Jordan, B. C., & Ranganna, K. (2016) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2016.01.051 · Cited by 2
Cited by
Computational approaches streamlining drug discovery
Sadybekov, A. V., & Katritch, V. (2023) · Nature · doi:10.1038/s41586-023-05905-z · Cited by 1,279
G protein-coupled receptors: structure- and function-based drug discovery
Yang, D., Zhou, Q., Labroska, V., Qin, S., Darbalaei, S., Wu, Y., Yuliantie, E., Xie, L., Tao, H., Cheng, J., et al. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00435-w · Cited by 632
G protein-coupled receptors (GPCRs): advances in structures, mechanisms and drug discovery
Zhang, M., Chen, T., Lu, X., Lan, X., Chen, Z., & Lu, S. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01803-6 · Cited by 491
Synthon-based ligand discovery in virtual libraries of over 11 billion compounds
Sadybekov, A. A., Sadybekov, A. V., Liu, Y., Iliopoulos-Tsoutsouvas, C., Huang, X.-P., Pickett, J., Houser, B., Patel, N., Tran, N. K., Tong, F., et al. (2022) · Nature · doi:10.1038/s41586-021-04220-9 · Cited by 417
Multi‐state modeling of G‐protein coupled receptors at experimental accuracy
Heo, L., & Feig, M. (2022) · Proteins: Structure, Function, and Bioinformatics · doi:10.1002/prot.26382 · Cited by 215
Metadata
- Authors
- Congreve, M., de Graaf, C., Swain, N. A., & Tate, C. G.
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 2020-04
- Volume
- 181
- Issue
- 1
- Pages
- 81-91
- ISSN
- 0092-8674 (ISSN-L)
- OpenAlex
- W3014501695
- Cited by
- 375
- References
- 100
- FWCI
- 14.52
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.